NCT01568944View on ClinicalTrials.gov

Role of Infected Blood Dendritic Cells in Heart Disease Risk

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Chronic Periodontitis
Interventions
DRUG

Oral Antibiotic and Oral Rinse

PO Amoxicillin in 500 mg / Metronidazole 250 mg of each TID for 8 days plus 2 ounces of 0.12% chlorhexidine mouthrinse used BID

PROCEDURE

Standard Treatment

Full mouth scaling and root planing using hand instrumentation (curettes) and ultrasonic scalers

Trial Locations (1)

30912

GHSU-CDM Clinical Research Center, Augusta

All Listed Sponsors
collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Augusta University

OTHER

NCT01568944 - Role of Infected Blood Dendritic Cells in Heart Disease Risk | Biotech Hunter | Biotech Hunter